However, high levels of IL-6, IL-10, and IL-8 in serum have been reported to negatively correlate with survival in pancreatic cancer patients, due to their role in stimulating inflammation and adverse changes in the tumor microenvironment that spurs the growth and development of pancreatic tumors (135, 136). This evidence concerns the gene IL6 and neoplasm.